1,297 results on '"Simó, Rafael"'
Search Results
152. Apolipoprotein A1 Is Overexpressed in the Retina of Diabetic Patients
153. Diabetic retinopathy independently predicts five-year risk of Alzheimer’s disease
154. Aula d'Ecologia : cicles de conferències 1999 i 2000
155. Can augmentation index substitute aortic pulse wave velocity in the assessment of central arterial stiffness in type 1 diabetes?
156. ERM Complex, a Therapeutic Target for Vascular Leakage Induced by Diabetes
157. Spectrum of thyroid dysfunction and dementia: a dose–response meta-analysis of 344,248 individuals from cohort studies
158. Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial
159. Neuroprotection in Diabetic Retinopathy
160. Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy
161. Metformin: a new option in cancer treatment
162. Vascular endothelial growth factor and diabetic complications
163. Asymptomatic Sleep-disordered Breathing in Premenopausal Women Awaiting Bariatric Surgery
164. Adiponectin Upregulates SHBG Production: Molecular Mechanisms and Potential Implications
165. Ocular Anti-VEGF Therapy for Diabetic Retinopathy: The Role of VEGF in the Pathogenesis of Diabetic Retinopathy
166. Oleic acid increases hepatic sex hormone binding globulin production in men
167. Is it time to change the management of permanent postsurgical hypoparathyroidism?
168. Complementary pre‐screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project.
169. Calorie Restriction and SIRT1 Overexpression Induce Different Gene Expression Profiles in White Adipose Tissue in Association with Metabolic Improvement
170. GH/IGF-1 Abnormalities and Muscle Impairment: From Basic Research to Clinical Practice
171. Acromegaly: Diabetes and HOMA-IR
172. Diabetes y HOMA-IR en la acromegalia
173. Canagliflozin: A New Therapeutic Option in Patients That Present Postprandial Hyperinsulinemic Hypoglycemia after Roux-en-Y Gastric Bypass: A Pilot Study
174. Standardization of Optical Coherence Tomography Angiography Imaging Biomarkers in Diabetic Retinal Disease
175. Additional file 1 of Non-linear association between diabetes mellitus and pulmonary function: a population-based study
176. Pre‐screening models for patient engagement: The MOPEAD project
177. Sex hormone-binding globulin overexpression protects against high-fat diet-induced obesity in transgenic male mice
178. HOMA-IR in acromegaly: a systematic review and meta-analysis
179. Identification of new pathogenic candidates for diabetic macular edema using fluorescence-based difference gel electrophoresis analysis
180. Overexpression of Hemopexin in the Diabetic Eye: A new pathogenic candidate for diabetic macular edema
181. Topical Administration of Somatostatin Prevents Retinal Neurodegeneration in Experimental Diabetes
182. Neurodegeneration, Neuropeptides, and Diabetic Retinopathy
183. Measuring Permeability in Human Retinal Epithelial Cells (ARPE-19): Implications for the Study of Diabetic Retinopathy
184. IL1β Down-regulation of Sex Hormone-Binding Globulin Production by Decreasing HNF-4α Via MEK-1/2 and JNK MAPK Pathways
185. Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications
186. Liraglutide Improves Forced Vital Capacity in Individuals With Type 2 Diabetes: Data From the Randomized Crossover LIRALUNG Study.
187. Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: A case-control study
188. Serum markers of vascular inflammation in dyslipemia
189. Growth Factors in the Diabetic Eye
190. Arterial Stiffness Is Increased in Patients With Type 1 Diabetes Without Cardiovascular Disease: A potential role of low-grade inflammation
191. Molecular Mechanism of TNFα-Induced Down-Regulation of SHBG Expression
192. Potential Role of Tumor Necrosis Factor-α in Downregulating Sex Hormone–Binding Globulin
193. Study of the Potential Association of Adipose Tissue GLP-1 Receptor with Obesity and Insulin Resistance
194. Beneficial Effects of Glucagon-Like Peptide-1 (GLP-1) in Diabetes-Induced Retinal Abnormalities: Involvement of Oxidative Stress
195. Clinical Applicability of the Specific Risk Score of Dementia in Type 2 Diabetes in the Identification of Patients with Early Cognitive Impairment: Results of the MOPEAD Study in Spain
196. Effect of Type 2 Diabetes Mellitus on the Hypoxia-Inducible Factor 1-Alpha Expression. Is There a Relationship with the Clock Genes?
197. Effect of Topical Administration of Somatostatin on Retinal Inflammation and Neurodegeneration in an Experimental Model of Diabetes
198. Caffeine Upregulates Hepatic Sex Hormone‐Binding Globulin Production by Increasing Adiponectin Through AKT/FOXO1 Pathway in White Adipose Tissue
199. Utility of Insulin Resistance in Estimating Cardiovascular Risk in Subjects with Type 1 Diabetes According to the Scores of the Steno Type 1 Risk Engine
200. Combining metabolic profiling of plasma and faeces as a fingerprint of insulin resistance in obesity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.